Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Iaith wreiddiol	Saesneg
Tudalennau (o-i)	335-342
Cyfnodolyn	Pharmacogenetics
Cyfrol	14
Rhif cyhoeddi	6
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.1097/00008571-200406000-00002
Statws	Cyhoeddwyd - 1 Meh 2004

Mynediad at Ddogfen

@article{efaeff2318bf4daf96e171c01ea89590,

title = "Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity",

keywords = "BIOTECHNOLOGY \& APPLIED MICROBIOLOGY, GENETICS \& HEREDITY, PHARMACOLOGY \& PHARMACY",

author = "D. Hughes and D.A. Hughes and F.J. Vilar and C.C. Ward and A. Alfirevic and B.K. Park and M. Pirmohamed",

year = "2004",

month = jun,

day = "1",

doi = "10.1097/00008571-200406000-00002",

language = "English",

volume = "14",

pages = "335--342",

journal = "Pharmacogenetics",

issn = "0960-314X",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

AU - Hughes, D.

AU - Hughes, D.A.

AU - Vilar, F.J.

AU - Ward, C.C.

AU - Alfirevic, A.

AU - Park, B.K.

AU - Pirmohamed, M.

PY - 2004/6/1

Y1 - 2004/6/1

KW - BIOTECHNOLOGY & APPLIED MICROBIOLOGY

KW - GENETICS & HEREDITY

KW - PHARMACOLOGY & PHARMACY

U2 - 10.1097/00008571-200406000-00002

DO - 10.1097/00008571-200406000-00002

M3 - Article

SN - 0960-314X

VL - 14

SP - 335

EP - 342

JO - Pharmacogenetics

JF - Pharmacogenetics

IS - 6

ER -